This reflects the rapidly rising demand and expanding use of GLP-1 therapies across the globe
Zonulin is composed of two chains, an A chain and a B chain
At the extracellular region, neuromedin C engages a cluster of hydrophobic and aromatic residues (L141, L144, Y145, Y148, Y152) consistent with peptide recognition and anchoring at the receptor surface
Heres a chart, based on data from this study: People with obesity or metabolic syndrome have chronically high GLP-1 levels, possibly because the diet that tends to cause obesity and metabolic syndrome is high in sugar and simple carbs, which raise blood sugar and demand a lot of GLP-1
More recent studies have refined this definition by differentiating it into oxidative eustress or oxidative distress
2004;53(suppl 3):S16-S21